-
B126453-10mgPotent, selective γ-secretase inhibitor.
-
B126453-1mgPotent, selective γ-secretase inhibitor.
-
B126453-50mgPotent, selective γ-secretase inhibitor.
-
B126453-5mgPotent, selective γ-secretase inhibitor.
-
A129676-1gAvanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >:121-fold selectivity over other PDEs.
-
A129676-250mgAvanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >:121-fold selectivity over other PDEs.
-
A129676-25gAvanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >:121-fold selectivity over other PDEs.
-
A129676-50mgAvanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >:121-fold selectivity over other PDEs.
-
A129676-5gAvanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >:121-fold selectivity over other PDEs.
-
A414052-100mgInformationAvapritinib (BLU-285) is a small molecule kinase inhibitor that potently inhibitsPDGFRα D842Vmutant activity in vitro (IC50 = 0.5 nM) and PDGFRα D842V autophosphorylation in the cellular setting (IC50 = 30 nM): also a potent inhibitor of
-
A414052-10mgInformationAvapritinib (BLU-285) is a small molecule kinase inhibitor that potently inhibitsPDGFRα D842Vmutant activity in vitro (IC50 = 0.5 nM) and PDGFRα D842V autophosphorylation in the cellular setting (IC50 = 30 nM): also a potent inhibitor of
-
A414052-1mgInformationAvapritinib (BLU-285) is a small molecule kinase inhibitor that potently inhibitsPDGFRα D842Vmutant activity in vitro (IC50 = 0.5 nM) and PDGFRα D842V autophosphorylation in the cellular setting (IC50 = 30 nM): also a potent inhibitor of